Pelthos Therapeutics Inc. (PTHS) — Defensive Interval Ratio

Latest as of December 2025: 124 days

Pelthos Therapeutics Inc. (PTHS) has a Defensive Interval Ratio of 124 days as of December 2025. Defensive assets of $8.86 Million (cash $-, short-term investments $-, receivables $8.86 Million) cover 124 days of daily cash needs of $71.21K/day. See PTHS current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

124 days
Days of operational coverage

Defensive Assets

$8.86 Million
Cash + ST Investments + Receivables

Daily Cash Need

$71.21K
Current Liabilities ÷ 365

Current Liabilities

$25.99 Million
USD

Pelthos Therapeutics Inc. Defensive Interval Ratio (2024–2025)

This chart shows how Pelthos Therapeutics Inc.'s Defensive Interval Ratio has evolved across 2 annual periods from 2024 to 2025. As of December 2025, the ratio stands at 124 days, meaning defensive assets of $8.86 Million can fund 124 days of operations without new revenue. See Pelthos Therapeutics Inc. balance sheet quality to measure how much of total assets are equity-financed.

Annual Defensive Interval Ratio for Pelthos Therapeutics Inc. (2024–2025)

The table below presents the year-by-year Defensive Interval Ratio for Pelthos Therapeutics Inc. from 2024 to 2025, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see market cap of Pelthos Therapeutics Inc..

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2025 124 days $8.86 Million $71.21K/day $- $- ▲ +121 days
2024 4 days $40.40K $11.19K/day $- $-
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)